U.S. Inter-Agency Group takes on Counterfeit Pharmaceuticals

U.S. Inter-Agency Group takes on Counterfeit Pharmaceuticals

The Office of the Intellectual Property Enforcement Coordinator released an Inter-Agency report partnering with the Food and Drug Administration, U.S. Customs and Border Protection, U.S. Immigration and Customs Enforcement, and the Departments of Justice, State, and Commerce and USAID.

The report highlights the Administration’s efforts to combat counterfeit pharmaceuticals listing various Department initiatives and in some cases providing actual budget numbers (State Department budgets $1.3 million in 2011 to combat counterfeit pharmaceuticals). 

Finally, the report provides the Vice President and Congress some legislative fixes they deem appropriate to help combat counterfeit pharmaceuticals.  Recommendations include mandatory disclosure by importers and manufacturers when they discover counterfeit drugs or medical products, the adoption of a “Track-and-Trace” system, and the group recommends increasing penalties for counterfeiters.